首页> 外文期刊>BMC Pulmonary Medicine >Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study
【24h】

Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study

机译:肺活量和吸气量作为评估哮喘患者支气管扩张剂反应的附加参数:一项横断面研究

获取原文
           

摘要

Background Bronchodilator response in patients with asthma is evaluated based on post-bronchodilator increase in forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). However, the need for additional parameters, mainly among patients with severe asthma, has already been demonstrated. Methods The aim of this study was to evaluate the usefulness of vital capacity (VC) and inspiratory capacity (IC) to evaluate bronchodilator response in asthma patients with persistent airflow obstruction. The 43 asthma patients enrolled in the study were stratified into moderate or severe airflow obstruction groups based on baseline FEV1. All patients performed a 6-minute walk test before and after the bronchodilator (BD). A bipolar visual analogue scale post-BD was performed to assess clinical effect. The correlation between VC and IC and clinical response, determined by visual analogue scale (VAS) and 6-minute walk test (6MWT), was investigated. Results Patients in the severe group presented: 1) greater bronchodilator response in VC (48% vs 15%, p?=?0.02), 2) a significant correlation between VC variation and the reduction in air trapping (Rs?=?0.70; p? Conclusions VC may be a useful additional parameter to evaluate bronchodilator response in asthma patients with severe airflow obstruction.
机译:背景哮喘患者的支气管扩张剂反应是根据支气管扩张剂后一秒钟的呼气量(FEV 1 )和强制肺活量(FVC)的增加来评估的。但是,已经证明了主要在重度哮喘患者中需要额外的参数。方法本研究的目的是评估肺活量持续性阻塞患者的肺活量(VC)和吸气量(IC)评估支气管扩张药反应的有效性。根据基线FEV 1 将参与研究的43名哮喘患者分为中度或重度气流阻塞组。所有患者在支气管扩张剂(BD)前后进行了6分钟的步行测试。 BD后进行双极视觉模拟量表以评估临床效果。研究了视觉模拟量表(VAS)和6分钟步行测试(6MWT)确定的VC和IC与临床反应之间的相关性。结果严重组患者表现为:1)VC支气管扩张剂反应增强(48%比15%,p <= 0.02),2)VC变异与减少空气滞留之间存在显着相关性(Rs == 0.70;结论VC可能是评估严重气流阻塞的哮喘患者支气管扩张药反应的有用的附加参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号